Please join your Goodwin team as we host SRS Acquiom for a breakfast event and panel discussion surrounding the launch of their newly released 2019 Life Sciences M&A Study, which focuses on structured M&A activity. SRS Acquiom’s recently released 2019 Life Sciences M&A Study gives a detailed look at deal terms and earnout achievement rates by year, sector and stage of development. The study draws from SRS Acquiom's experience as a professional shareholder representative on more than 100 structured life sciences deals involving almost 1,000 milestones potentially worth over $30 billion.
Click here to download a copy of the study.
Discussions will include:
- Key issues in negotiating these agreements
- Best practices for optimizing outcomes after the deal is announced
- An analysis of which milestones actually get paid, and when
Tuesday, 19 November 2019
8:30 am – 10:30 am
Registration with Breakfast + Coffee | 8:30 am – 9:00 am
Panel Discussion | 9:00 am – 10:30 am
Goodwin's London Office
100 Cheapside | London EC2V 6DY
Please click here to register.
Sophie C. McGrathPartner